The World Anti-Doping Agency (WADA) has launched an investigation into the UK Anti-Doping Agency (UKAD) after claims that British Cycling were able to carry out their own investigation into a cyclists sample, which allegedly contained a prohibited anabolic steroid.
The claims from British news organisation, the Mail On Sunday, came in the wake of British Cycling's former chief doctor Richard Freeman being struck off the medical register, after a tribunal found that he had ordered the banned steroid testosterone.
In response to the allegations, UKAD released a statement: "We are working with the World Anti-Doping Agency to investigate claims relating to private testing carried out by British Cycling in 2011.
"UKAD is examining archives to confirm decisions that were taken in 2011 followed due process set by WADA."
An out-of-competition test that was undertaken in late 2010 is said to have revealed that a British riders sample contained irregular levels of nandrolone, which is a threshold substance, meaning that an amount found in a sample needs to be above a certain threshold to trigger action by an anti-doping organisation.
The WADA code dictates that UKAD must launch the investigation themselves, however the report claimed that UKAD alerted British Cycling, who in turn, conducted their own investigation.
"Some of the information provided to WADA on this is of significant concern," a WADA spokesperson said.
"We have asked our independent Intelligence and Investigations Department to look into this matter and to contact UKAD to seek further information."
A UKAD spokesperson added: "Sometimes amounts of a 'threshold substance' can be reported by the laboratory in a negative sample which are found to be below the threshold where an investigation is required.
"These are trace amounts and can sometimes occur in the body naturally.
"The guidance from WADA is that these trace findings may be used to help to decide who gets tested and when in the future, but does not automatically lead to an investigation."
Author: Jake Wilkin